Advances in the prevention, management, and treatment of community-acquired pneumonia

Mathias W. Pletz*, Gernot Rohde, Tobias Welte, Martin Kolditz, Sebastian Ott

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Community-acquired pneumonia (CAP) is the infectious disease with the highest number of deaths worldwide. Nevertheless, its importance is often underestimated. Large cohorts of patients with CAP have been established worldwide and improved our knowledge about CAP by far. Therefore, current guidelines are much more evidence-based than ever before. This article discusses recent major studies and concepts on CAP such as the role of biomarkers, appropriate risk stratification to identify patients in need of hospitalisation or intensive care, appropriate empiric antibiotic therapy (including the impact of macrolide combination therapy and antibiotic stewardship), and CAP prevention with novel influenza and pneumococcal vaccines.
Original languageEnglish
Number of pages11
Issue number300
Publication statusPublished - 2016


Dive into the research topics of 'Advances in the prevention, management, and treatment of community-acquired pneumonia'. Together they form a unique fingerprint.

Cite this